GMED
Globus Medical
NYSE: GMED · HEALTHCARE · MEDICAL DEVICES
$90.18
+2.72% today
Updated 2026-04-30
Market cap
$11.91B
P/E ratio
22.40
P/S ratio
4.05x
EPS (TTM)
$3.92
Dividend yield
—
52W range
$52 – $101
Volume
1.1M
Globus Medical (GMED) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $32.08M | $71.29M | $76.41M | $76.52M | $93.47M | $79.17M | $121.96M | $171.89M | $159.53M | $181.64M | $171.97M | $198.79M | $276.27M | $178.47M | $243.50M | $520.64M | $753.45M |
| Capital expenditures | $25.96M | $12.30M | $22.49M | $24.68M | $23.68M | $24.75M | $50.76M | $40.91M | $51.30M | $59.70M | $70.75M | $63.66M | $56.90M | $74.05M | $78.27M | $115.43M | $164.68M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $3.51M | $4.03M | $3.29M | $4.63M | $5.18M | $7.11M | $9.64M | $11.38M | $14.69M | $21.90M | $26.09M | $27.07M | $30.59M | $32.81M | $52.74M | $54.19M | $49.78M |
| Free cash flow | $6.12M | $58.98M | $53.92M | $51.84M | $69.79M | $54.42M | $71.20M | $130.98M | $108.23M | $121.95M | $101.22M | $135.13M | $219.38M | $104.42M | $165.22M | $405.21M | $588.77M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $69.73M | $-122.44M | $-7.70M | $-22.11M | $72.49M | $51.86M | $20.93M | — | $42.81M | $-45.52M | $-41.86M | — | — | — |